What are the side effects of clarithromycin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clarithromycin Side Effects

The most common side effects of clarithromycin include epigastric distress, abdominal cramps, nausea, vomiting, and diarrhea, with gastrointestinal symptoms occurring in approximately 9-11% of patients. 1

Common Side Effects

  • Gastrointestinal effects are the most frequently reported adverse reactions:

    • Abdominal pain/epigastric distress 1, 2
    • Diarrhea (6% incidence) 3
    • Nausea (3% incidence) 3
    • Vomiting 1, 2
    • Abnormal/metallic taste (7% incidence) 3, 2
  • Other common side effects include:

    • Headache 4
    • Insomnia 4
    • Rash 4
    • Dysgeusia (altered taste) 2

Serious Side Effects

  • Hepatotoxicity (liver function abnormalities) 4, 5

    • Elevated liver enzymes may develop in approximately 38% of elderly patients on high doses 5
  • Hypersensitivity reactions:

    • Skin rashes 1
    • Drug fever 1
    • Eosinophilia 1
    • Anaphylaxis (rare) 1
  • Clostridium difficile-associated diarrhea (CDAD) 4

    • Can range from mild diarrhea to fatal colitis
    • May occur up to two months after treatment
  • QT prolongation (risk of cardiac arrhythmias) 4

    • Particularly concerning in elderly patients
  • Exacerbation of myasthenia gravis 4

Special Population Considerations

  • Elderly patients:

    • More susceptible to side effects, particularly at high doses 5
    • May require dose reduction due to decreased renal function 4
    • Higher risk of torsades de pointes arrhythmias 4
  • Pregnant women:

    • Classified as FDA Pregnancy Category C 1
    • May cause fetal harm based on animal studies 4
    • Not recommended during pregnancy except when no alternatives exist 4
  • Nursing mothers:

    • Passes into breast milk 4
    • Approximately 1-2% of maternal weight-adjusted dose 4
    • May cause adverse reactions in breastfed infants including rash, diarrhea, loss of appetite, and somnolence 4

Drug Interactions

  • Inhibits cytochrome P450 enzyme system (CYP3A) 1, 6

    • Can increase blood levels of drugs metabolized by this pathway
  • Contraindicated with:

    • Astemizole 1
    • Cisapride 1
    • Pimozide 1
    • Terfenadine 1
    • Ergot alkaloids 4
  • Requires caution with:

    • Oral anticoagulants (increased risk of bleeding) 4
    • Benzodiazepines (increased sedation) 4
    • Quetiapine (increased exposure and toxicity) 4
    • Statins (increased risk of myopathy) 1
    • Calcium channel blockers (risk of acute kidney injury, especially in elderly) 4
    • Colchicine (increased toxicity) 4

Dosage Considerations

  • Standard adult dose: 500 mg twice daily or 1000 mg once daily (extended-release) for 7-14 days 1, 7

  • Dose adjustment needed in:

    • Severe renal impairment 4, 6
    • Elderly patients with low body weight 2, 5
  • Extended-release formulation:

    • Should be taken with food 4
    • May have improved gastrointestinal tolerability compared to immediate-release 3

Monitoring Recommendations

  • Monitor for gastrointestinal symptoms (most common adverse effects) 1
  • Periodic liver function tests, especially in the first 3 months of therapy 1
  • Monitor for signs of QT prolongation in at-risk patients 4
  • Watch for signs of Clostridium difficile infection (diarrhea) 4
  • Monitor drug levels and effects of medications with potential interactions 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clarithromycin-Associated Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clarithromycin extended-release tablet: a review of its use in the management of respiratory tract infections.

American journal of respiratory medicine : drugs, devices, and other interventions, 2003

Research

Drug intolerance to high-dose clarithromycin among elderly patients.

Diagnostic microbiology and infectious disease, 1993

Research

Clinical pharmacokinetics of clarithromycin.

Clinical pharmacokinetics, 1999

Guideline

Dosis de Claritromicina para Bronquitis Bacteriana

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.